Release Date: 18/10/19 12:56 Summary: Notice of Quarterly Results and Investor Conference Call Price Sensitive: No Download Document 154.49KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%